VAST’s flexible architecture allows us the choice to seamlessly scale storage computing and capacity entirely independently, which is complicated with other solutions on the market. As we look to the future, we envision launching other methods of processing designed to discover rare diseases and cancers. As we evolve - each new pipeline will require more I/O, but not necessarily more storage volume. That's clearly an advantage to using VAST, we’re able to design a system where there’s no ‘wasted storage’ in our infrastructure.
Alban Lermine
Bioinformatics Director, SeqOIA